Deerfield Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $166M | Buy |
|
|||||
|
2025
Q2 | $147M | Sell |
|
|||||
|
2025
Q1 | $165M | Buy |
|
|||||
|
2024
Q4 | $118M | Sell |
|
|||||
|
2024
Q3 | $152M | Buy |
|
|||||
|
2024
Q2 | $95.1M | Hold |
|
|||||
|
2024
Q1 | $95.3M | Sell |
|
|||||
|
2023
Q4 | $118M | Sell |
|
|||||
|
2023
Q3 | $136M | Hold |
|
|||||
|
2023
Q2 | $114M | Sell |
|
|||||
|
2023
Q1 | $177M | Buy |
|
|||||
|
2022
Q4 | $181M | Hold |
|
|||||
|
2022
Q3 | $161M | Sell |
|
|||||
|
2022
Q2 | $196M | Buy |
|
|||||
|
2022
Q1 | $155M | Buy |
|
|||||
|
2021
Q4 | $117M | Buy |
|
|||||
|
2021
Q3 | $110M | Buy |
|
|||||
|
2021
Q2 | $70.6M | Hold |
|
|||||
|
2021
Q1 | $70.5M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $788K | Sell |
|
|||||
|
2014
Q1 | $1.26M | Buy |
|